Breaking News Instant updates and real-time market news.

ANTM

Anthem

$301.05

13.18 (4.58%)

, CI

Cigna

$176.53

16.02 (9.98%)

13:22
07/11/19
07/11
13:22
07/11/19
13:22

Stephens raises targets for Anthem, Cigna, peers on HHS rebate rule withdrawal

Following press reports that the White House has withdrawn its proposed rule to eliminate drug rebates in Medicare/Medicaid outside point of sale, Stephens analyst Scott Fidel raised his price targets on a number of managed care stocks, calling the elimination of this key near-term overhang a "material positive event" for the MCO and PBM group. He raised his price target on Anthem (ANTM) to $350 from $335, upped his target on Cigna (CI) to $240 from $225, increased his target on Humana (HUM) to $320 from $300 and raised his target on UnitedHealth (UNH) to $290 from $270. Fidel keeps Overweight ratings on all four of those stocks. He also raised his target on Magellan Health (MGLN) to $74 from $70, though he keeps an Equal Weight rating on that stock, citing the company's softer fundamentals.

ANTM

Anthem

$301.05

13.18 (4.58%)

CI

Cigna

$176.53

16.02 (9.98%)

HUM

Humana

$278.84

10.92 (4.08%)

MGLN

Magellan Health

$71.49

-1.12 (-1.54%)

UNH

UnitedHealth

$260.48

13 (5.25%)

  • 18

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 09

    Sep

  • 13

    Nov

ANTM Anthem
$301.05

13.18 (4.58%)

06/25/19
SBSH
06/25/19
NO CHANGE
SBSH
Molina, Centene have most at stake from Texas Medicaid awards, says Citi
Citi analyst Ralph Giacobbe noted that Texas' "highly anticipated" STAR+PLUS contract for the states' higher acuity Medicaid members is expected to be awarded this Friday, June 28. Among the incumbents in the state, Molina (MOH) and Centene (CNC) have the most at stake, as their respective STAR+PLUS earnings contribute about 7% and 2%, respectively, of his and consensus estimates, Giacobbe tells investors. He estimates that the other incumbents - Anthem (ANTM), Cigna (CI) and UnitedHealth (UNH) - have 1% or less of their earnings at stake, adding that investor expectations are for the incumbents to largely retain business.
05/16/19
COWN
05/16/19
NO CHANGE
COWN
Move lower in managed care stocks appears overdone, says Cowen
Cowen analyst Charles Rhyee lowered his target multiple for the managed care group slightly from recent historical levels, but said he believes the recent weakness in the space on concerns around "Medicare for All," the rebate rule and the Texas ACA decision appears overdone. The discount for managed care stocks relative to the broader market has risen to a multi-year high, but he argues that underlying market fundamentals are stronger than in the pre-ACA era and Rhyee contends that there is "still plenty of growth left" in the managed care space, particularly in government-sponsored business. Stocks in the group include Anthem (ANTM), Cigna (CI), Centene (CNC), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
07/11/19
RAJA
07/11/19
NO CHANGE
RAJA
Death of drug rebate rule a win for PBMs and distributors, says Raymond James
After multiple media outlets, including Politico, reported that the Trump Administration has decided to withdraw the drug rebate rule, Raymond James analyst Chris Meekins called the news "a win" for pharmacy benefit managers and drug distributors and "a slight negative" for the pharmaceutical makers. The cost of the proposal to the government was ultimately too high with little guarantee that list prices would go down, said Meekins. However, President Trump hinted something "major" on drug pricing was coming over the next week during his kidney care speech and the analyst thinks the President is planning to move forward with an executive order on pricing. Publicly traded pharmaceutical distributors include McKesson (MCK), Cardinal Health (CAH), Amerisource (ABC) and Patterson (PDCO). Owners of pharmacy benefit managers include CVS Health (CVS), UnitedHealth (UNH), Anthem (ANTM) and Cigna (CI). Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
06/20/19
JEFF
06/20/19
NO CHANGE
JEFF
Amazon's PillPack looking to bypass PBMs, says Jefferies
Jefferies analyst Brian Tanquilut says his review of documents related to a case filed by CVS Health (CVS), which seeks to prevent a former CVS executive from joining PillPack, shows that Amazon.com (AMZN) is seeking to develop a service offering that would bypass pharmacy benefit managers and contract directly with payors. While it is difficult to predict the success of PillPack's efforts to bypass existing prescription payment structures, the court disclosure is a potential negative for PBMs like CVS Health, UnitedHealth (UNH), Anthem (ANTM) and Cigna (CI), Tanquilut tells investors in a research note.
CI Cigna
$176.53

16.02 (9.98%)

06/03/19
SBSH
06/03/19
NO CHANGE
Target $203
SBSH
Buy
Cigna price target lowered to $203 from $228 at Citi
Citi analyst Ralph Giacobbe lowered his price target for Cigna to $203 from $228 to reflect the recent "re-rating" of the managed care group. Cigna is now a "show me" story that will take some time, Giacobbe tells investors in a research note. The analyst, however, remains bullish on the shares following the company's analyst day and he keeps a Buy rating on the name.
HUM Humana
$278.84

10.92 (4.08%)

05/07/19
SBSH
05/07/19
NO CHANGE
SBSH
Citi sees low likelihood of Centene walking from WellCare deal
Amid reports suggesting shareholders could challenge Centene's (CNC) acquisition of WellCare (WCG), and Humana (HUM) possibly being interested in a takeover of Centene if the WellCare deal was dropped, Citi analyst Ralph Giacobbe says he's be surprised to see the deal unravel. Further, he'd be equally surprised to see Humana come over the top for Centene after its Medicaid win in Florida and recent commentary citing optimism in its organic direction. That said, there is a scarcity of Medicaid assets, and Humana has discussed its interest in dual and other higher acuity Medicaid populations, Giacobbe tells investors in a research note. Nonetheless, the analyst ultimately sees a low likelihood of Centene walking from the WellCare deal.
05/10/19
05/10/19
UPGRADE

Citi upgrades Anthem, Centene, UnitedHealth to Buy after 'extreme' selloff
Citi analyst Ralph Giacobbe upgraded Anthem (ANTM), Centene (CNC), and UnitedHealth (UNH) to Buy from Neutral while maintaining Buy ratings on Cigna (CI) and Humana (HUM). The magnitude of the selloff in managed care stocks on fears of Medicare for All has been "extreme and overdone," Giacobbe tells investors in a research note. The analyst sees favorable risk/rewards in the sector and does not subscribe to the view of a continued "overhang" and "uncertainty." Instead, Giacobbe expects a share recovery as "more realistic views prevail and investors become more numb to the low-likelihood headlines and political rhetoric of single payor."
06/03/19
CANT
06/03/19
NO CHANGE
Target $83
CANT
Overweight
Centene weakness due to Humana disclosure 'overdone,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Steven Halper notes that Humana (HUM) released an 8-K filing confirming it will not make a proposal to acquire Centene (CNC). With speculation around Humana's involvement casting doubt on Centene's pending merger with WellCare (WCG), the analyst says the news increases his confidence that the merger will be completed by the third quarter of 2020, and continues to believe that the company's merger with WellCare makes sense and should create significant value. Halper expects Centene-WellCare will have to divest certain Medicaid assets given the overlap in some states, but he believes that the acquisition will ultimately be completed by the company's estimated timeline. The analyst has an Overweight rating and $83 price target on Centene's shares.
MGLN Magellan Health
$71.49

-1.12 (-1.54%)

01/14/19
SPHN
01/14/19
INITIATION
Target $68
SPHN
Equal Weight
Magellan Health initiated with an Equal Weight at Stephens
Stephens analyst Scott Fidel initiated coverage of 11 Managed Care and Healthcare Facilities stocks, telling investors that overall he is constructive on managed care and selective on hospitals. He started Magellan Health with an Equal Weight rating and $68 price target, citing what he calls its "disappointing fundamental execution" in 2018. While the emergence of an activist investor will likely increase accountability and urgency, he would wait for some initial signs of improving business trends before getting more constructive, Fidel tells investors.
02/22/19
BOFA
02/22/19
INITIATION
Target $84
BOFA
Buy
Magellan Health initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Kevin Fischbeck initiated Magellan Health with a Buy and price target of $84.
02/20/19
LEER
02/20/19
NO CHANGE
LEER
Market Perform
Magellan Health buyout 'reasonable' up to $90 per share, says SVB Leerink
SVB Leerink analyst Ana Gupte says a takeout of Magellan Health (MGLN) "would be reasonable" up to $90 per share based on a sum-of-the-parts analysis. The stock in midday trading is up 10% to $71.28 after Reuters reported that the company is working with Goldman Sachs to gauge takeover interest. Activist hedge fund Starboard Value, which owns a 9.8% stake in Magellan, is likely to be pushing for a management shake-out, margin turnaround and eventual takeout by a strategic buyer such as Centene (CNC), Anthem (ANTM), UnitedHealth (UNH), WellCare (WCG) or Humana (HUM), Gupte tells investors in an intraday research note. The analyst suspects strategic buyers could pay a 25%-35% premium toward a takeout price of $90 to $95 per share post a margin turnaround. Gupte has a Market Perform rating on Magellan Health.
02/20/19
SPHN
02/20/19
NO CHANGE
Target $68
SPHN
Equal Weight
Magellan's most logical strategic buyer would be in managed care, says Stephens
After Reuters reported earlier today that Magellan Health (MGLN) is exploring a sale of the company amid pressure from activist Starboard Value, Stephens analyst Scott Fidel said he thinks the most logical strategic buyer would be in the managed care sector and he compiled a list of some companies he thinks could make sense as buyers, but cautioned that his list is "certainly not exhaustive." Anthem (ANTM), Humana (HUM), UnitedHealth (UNH), WellCare (WCG) and Centene (CNC) make Fidel's list of potential strategic buyers of Magellan and he sees various scenarios where the company could be valued at as low as $51 per share to as high as $106 per share in a takeout deal. Fidel keeps an Equal Weight rating and $68 price target on shares of Magellan, which are up $7.76, or 12%, to $72.78 in afternoon trading.
UNH UnitedHealth
$260.48

13 (5.25%)

07/11/19
CHLM
07/11/19
NO CHANGE
Target $84
CHLM
Buy
Tandem Diabetes a clear beneficiary of Medtronic recall, says Craig-Hallum
Craig-Hallum analyst Alexander Nowak believes Tandem Diabetes (TNDM) and to a lesser extent Insulet (PODD) are the "clear beneficiaries" of the FDA recalling 189,000 Medtronic (MDT) 600-series pumps. The recall should further assist Tandem's share gains over the next several quarters and perhaps years, Nowak tells investors in a research note. And while UnitedHealth (UNH) has an exclusive contract with Medtronic Diabetes, the recall is further data Tandem can use to negotiate with UnitedHealth and argue for inclusion in its network, adds the analyst. He reiterates a Buy rating on shares of Tandem Diabetes with an $84 price target.
07/08/19
BOFA
07/08/19
NO CHANGE
Target $75
BOFA
Neutral
Inspire Medical price target raised to $75 from $65 at BofA/Merrill
BofA/Merrill analyst Bob Hopkins raised his price target for Inspire Medical (INSP) to $75 from $65 after the company announced that United Healthcare (UNH) will provide coverage for Inspire's obstructive sleep apnea therapy as of August 1. In a research note to investors, Hopkins, who maintains a Neutral rating on Inspire, says it takes about 2-4 months for a patient insured by United to work their way through the prior-authorization, but Inspire now estimates that it will take just five days to get approval if a patient meats the restrictions set by United. Hopkins sees potential upside to Street numbers later in 2019 and 2022, but believes his positive outlook is largely reflected in the current stock price.

TODAY'S FREE FLY STORIES

THS

TreeHouse

$54.53

-0.2 (-0.37%)

04:53
07/18/19
07/18
04:53
07/18/19
04:53
Upgrade
TreeHouse rating change  »

TreeHouse upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

NGVT

Ingevity

$101.24

-1.5 (-1.46%)

04:50
07/18/19
07/18
04:50
07/18/19
04:50
Initiation
Ingevity initiated  »

Ingevity initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

BV

BrightView

$17.83

-0.435 (-2.38%)

04:48
07/18/19
07/18
04:48
07/18/19
04:48
Downgrade
BrightView rating change  »

BrightView downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

SONM

Sonim

$13.80

-0.08 (-0.58%)

04:46
07/18/19
07/18
04:46
07/18/19
04:46
Initiation
Sonim initiated  »

Sonim initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Sep

BK

BNY Mellon

$44.13

1 (2.32%)

04:46
07/18/19
07/18
04:46
07/18/19
04:46
Upgrade
BNY Mellon rating change  »

BNY Mellon upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

SAN

Banco Santander

$4.55

-0.095 (-2.05%)

04:43
07/18/19
07/18
04:43
07/18/19
04:43
Downgrade
Banco Santander rating change  »

Banco Santander…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

03:45
07/18/19
07/18
03:45
07/18/19
03:45
General news
FX Action: USD-CAD has settled lower »

FX Action: USD-CAD has…

SWDBY

Swedbank

$0.00

(0.00%)

21:49
07/17/19
07/17
21:49
07/17/19
21:49
Downgrade
Swedbank rating change at JPMorgan »

Swedbank downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULC

Fulcrum Therapeutics

$0.00

(0.00%)

20:53
07/17/19
07/17
20:53
07/17/19
20:53
Syndicate
Fulcrum Therapeutics 4.5M share IPO priced at $16.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

NFLX

Netflix

$362.50

-3.22 (-0.88%)

20:50
07/17/19
07/17
20:50
07/17/19
20:50
Recommendations
Netflix analyst commentary at Pivotal Research »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

PSMT

PriceSmart

$61.77

-0.43 (-0.69%)

20:43
07/17/19
07/17
20:43
07/17/19
20:43
Upgrade
PriceSmart rating change at Scotiabank »

PriceSmart upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMAB

Genmab

$0.00

(0.00%)

20:32
07/17/19
07/17
20:32
07/17/19
20:32
Syndicate
Genmab 28.5M share IPO priced at $17.75 per ADS »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

POWI

Power Integrations

$79.67

-0.22 (-0.28%)

20:29
07/17/19
07/17
20:29
07/17/19
20:29
Upgrade
Power Integrations rating change at Stifel »

Power Integrations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

UNH

UnitedHealth

$266.71

2.11 (0.80%)

, HON

Honeywell

$168.81

-6 (-3.43%)

20:25
07/17/19
07/17
20:25
07/17/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

UNH

UnitedHealth

$266.71

2.11 (0.80%)

HON

Honeywell

$168.81

-6 (-3.43%)

PM

Philip Morris

$81.06

-0.49 (-0.60%)

UNP

Union Pacific

$164.05

-11.05 (-6.31%)

DHR

Danaher

$139.60

-0.22 (-0.16%)

MS

Morgan Stanley

$43.78

-0.63 (-1.42%)

BX

Blackstone

$45.27

-0.555 (-1.21%)

BBT

BB&T

$49.68

0.04 (0.08%)

STI

SunTrust

$63.99

0.08 (0.13%)

NUE

Nucor

$54.71

-0.87 (-1.57%)

GPC

Genuine Parts

$102.27

-3.07 (-2.91%)

ALLY

Ally Financial

$31.44

-0.26 (-0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 24

    Jul

  • 06

    Aug

  • 06

    Aug

  • 20

    Aug

  • 21

    Aug

  • 26

    Aug

  • 04

    Sep

  • 05

    Sep

  • 06

    Sep

  • 11

    Sep

  • 26

    Sep

  • 07

    Nov

ADTN

Adtran

$15.84

0.09 (0.57%)

20:07
07/17/19
07/17
20:07
07/17/19
20:07
Earnings
Adtran reports Q2 adjusted EPS 14c, consensus 8c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

BHC

Bausch Health

$22.91

-0.26 (-1.12%)

, PGNX

Progenics

$5.38

0.055 (1.03%)

19:52
07/17/19
07/17
19:52
07/17/19
19:52
Hot Stocks
NJ District Court upholds validity of Relistor patent »

Bausch Health (BHC) and…

BHC

Bausch Health

$22.91

-0.26 (-1.12%)

PGNX

Progenics

$5.38

0.055 (1.03%)

TEVA

Teva

$8.11

-0.07 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

  • 07

    Aug

  • 09

    Sep

EFC

Ellington Financial

$18.30

0.045 (0.25%)

19:31
07/17/19
07/17
19:31
07/17/19
19:31
Syndicate
Ellington Financial 3.5M share Spot Secondary priced at $17.66 »

Credit Suisse Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EPRT

Essential Properties Realty Trust

$19.83

-0.27 (-1.34%)

19:26
07/17/19
07/17
19:26
07/17/19
19:26
Syndicate
Essential Properties Realty Trust 22.86M share Secondary priced at $19.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

FTSV

Forty Seven

$8.77

-1.38 (-13.60%)

19:22
07/17/19
07/17
19:22
07/17/19
19:22
Syndicate
Forty Seven 9.38M share Secondary priced at $8.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 18

    Jul

SNDE

Sundance Energy

$1.67

-0.17 (-9.24%)

19:20
07/17/19
07/17
19:20
07/17/19
19:20
Hot Stocks
Sundance Energy to sell Dimmit County assets for $29.5M »

Sundance Energy Australia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYMT

New York Mortgage

$6.25

-0.01 (-0.16%)

19:18
07/17/19
07/17
19:18
07/17/19
19:18
Syndicate
New York Mortgage 20M share Spot Secondary priced at $6.11 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

IBKC

Iberiabank

$74.44

-0.7 (-0.93%)

18:57
07/17/19
07/17
18:57
07/17/19
18:57
Hot Stocks
Iberiabank raises quarterly dividend by 5% to 45c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 23

    Sep

IBKC

Iberiabank

$74.44

-0.7 (-0.93%)

18:56
07/17/19
07/17
18:56
07/17/19
18:56
Hot Stocks
Iberiabank authorizes 1.6M share repurchase program »

Iberiabank announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 23

    Sep

EBAY

eBay

$39.03

-0.87 (-2.18%)

, LLNW

Limelight Networks

$2.77

0.18 (6.95%)

18:52
07/17/19
07/17
18:52
07/17/19
18:52
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: eBay…

EBAY

eBay

$39.03

-0.87 (-2.18%)

LLNW

Limelight Networks

$2.77

0.18 (6.95%)

NFLX

Netflix

$362.50

-3.22 (-0.88%)

URI

United Rentals

$131.55

-6.05 (-4.40%)

CCK

Crown Holdings

$59.38

-0.88 (-1.46%)

AA

Alcoa

$23.15

-0.18 (-0.77%)

KMI

Kinder Morgan

$20.60

-0.3 (-1.44%)

TCBI

Texas Capital

$58.67

-0.76 (-1.28%)

IBM

IBM

$143.07

-0.47 (-0.33%)

AMRN

Amarin

$21.06

-0.68 (-3.13%)

ROKU

Roku

$109.33

-2.575 (-2.30%)

NYMT

New York Mortgage

$6.25

-0.01 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 17

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 07

    Aug

  • 26

    Aug

  • 23

    Sep

  • 28

    Sep

  • 18

    Jul

  • 19

    Jul

NFLX

Netflix

$362.50

-3.22 (-0.88%)

18:42
07/17/19
07/17
18:42
07/17/19
18:42
Hot Stocks
Breaking Hot Stocks news story on Netflix »

Netflix says will add $5B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.